Human SNP ID | rs6092078 |
---|---|
Human chromosome | chr20 |
Human SNP position | 55184590 |
Pig chromosome | chr17 |
Pig SNP position | 62974841 |
PubMed ID | 20195266 |
---|---|
Journal | Mol Psychiatry |
Link | www.ncbi.nlm.nih.gov/pubmed/20195266 |
Study | Genomewide pharmacogenomic study of metabolic side effects to antipsychotic drugs. |
Disease/Trait | Response to antipsychotic treatment |
Initial sample | 421 European ancestry, 214 African American, and 103 cases |
Replication sample | NA |
Region | 20q13.2 |
Chromosome id | chr20 |
Chromosome position | 55184590 |
Reported gene | intergenic |
Mapped gene | RPL12P4 - LINC01441 |
Upstream gene id | 116149 |
Downstream gene id | 101927796 |
SNP gene ids | |
Upstream gene distance | 109412 |
Downstream gene distance | 235746 |
SNP risk allele | rs6092078-? |
SNPs | rs6092078 |
Merged | 0 |
SNP id current | 6092078 |
Context | intergenic_variant |
Intergenic | 1 |
Allele frequency | 0.115 |
P value | 0.000003 |
Pvalue mlog | 5.52287874528033 |
P value text | (risperidone-hip circumference) |
Or beta | |
%95 Ci | |
Platform | Affymetrix [492900] |
CNV | N |
Mapped trait | response to risperidone |
Mapped trait URI | http://purl.obolibrary.org/obo/GO_0097336 |
Study accession | GCST000618 |